An analysis of the utilisation of chemoprophylaxis against Pneumocystis jirovecii pneumonia in patients with malignancy receiving corticosteroid therapy at a cancer hospital.

MLA

Worth, L. J., et al. “An Analysis of the Utilisation of Chemoprophylaxis against Pneumocystis Jirovecii Pneumonia in Patients with Malignancy Receiving Corticosteroid Therapy at a Cancer Hospital.” British Journal of Cancer, vol. 92, no. 5, Mar. 2005, pp. 867–72. EBSCOhost, https://doi.org/10.1038/sj.bjc.6602412.

APA

Worth, L. J., Dooley, M. J., Seymour, J. F., Mileshkin, L., Slavin, M. A., & Thursky, K. A. (2005). An analysis of the utilisation of chemoprophylaxis against Pneumocystis jirovecii pneumonia in patients with malignancy receiving corticosteroid therapy at a cancer hospital. British Journal of Cancer, 92(5), 867–872. https://doi.org/10.1038/sj.bjc.6602412

Chicago

Worth, L. J., M. J. Dooley, J. F. Seymour, L. Mileshkin, M. A. Slavin, and K. A. Thursky. 2005. “An Analysis of the Utilisation of Chemoprophylaxis against Pneumocystis Jirovecii Pneumonia in Patients with Malignancy Receiving Corticosteroid Therapy at a Cancer Hospital.” British Journal of Cancer 92 (5): 867–72. doi:10.1038/sj.bjc.6602412.